Berlin – Warsaw-listed stock corporation Grupa Azoty S.A. has entered into a conditional share purchase agreement for the acquisition of COMPO EXPERT group, headquartered in Münster, Germany, from XIO group, a London-headquartered private equity firm, following a competitive bidding process. The closing of the transaction is subject to certain conditions such as approval from merger control authorities and at the general shareholder's meeting of Grupa Azoty S.A. The purchase price for 100% of shares in the COMPO EXPERT Group will not be higher than EUR 235 million.
A team of CMS lawyers, including the lead partners Ralf Kurney and Dr. Igor Stenzel, has advised Grupa Azoty throughout the transaction, including coordinating legal due diligence in twelve jurisdictions with law firms from the CMS network and the World Law Group. Further, CMS has also advised Grupa Azoty on the bidding process and on antitrust issues and has jointly with the Grupa Azoty-team led the negotiations on the share purchase agreement. CMS, and in particular Dr. Igor Stenzel regularly advises Polish enterprises on M&A transactions and corporate law questions in Germany. Dr. Igor Stenzel speaks fluently Polish, English and German. According to him the size of the current transaction reflects the positive trend in German-Polish trade relations.
Grupa Azoty is a strong market leader in Poland and one of the key capital groups of the fertilizer and chemical industry in Europe. The Group is the second largest manufacturer of nitrogenous and compound fertilizers in the European Union. Other products produced by the Group, such as melamine, caprolactam, polyamide, plasticizers, OXO alcohols and titanium white, have an equally strong position in the chemical sector and are used across many industries.
COMPO EXPERT is a worldwide independent manufacturer of high value-added specialty fertilizers for professional end-users, offering advanced fertilizer solutions for a wide range of applications.
CMS Germany
Ralf Kurney, Lead Partner
Dr. Igor Stenzel, Lead Partner, both Corporate M&A
Dr. Tom Christopher Pröstler, Senior Associate, Dispute Resolution
Julian Hornberg, Associate
Vera Wahl, Associate, both Corporate M&A
Dr. Hanna Heimrath LL.M., Research Associate
Axel Dippmann, Partner
Alexander Schmitt, Counsel, both Banking & Finance
Marcus Fischer, Counsel, Tax
Dr. Sören Langner, Partner
Dr. Andreas Hofelich, Partner
Dr. Mario Brungs, Associate
Neil Yeats, Associate, all Labor, Employment & Pensions
Prof. Dr. Winfried Bullinger, Partner
Dr. Katharina Garbers-von Boehm, Counsel
Sabine Mußotter, Counsel
Alexis von Kruedener, Senior Associate, all Intellectual Property
Dr. Andreas Otto, Partner
Dr. Benjamin Schirmer, Counsel
Johannes Bescher, Senior Associate, all Real Estate & Public
Dr. Kai-Oliver Giesa, Counsel, Commercial
Dr. Rolf Hempel, Partner
Martin Cholewa, Senior Associate, both EU & Competition
CMS Austria
Dr. Dieter Zandler, Partner
CMS China
Dr. Ulrike Glück, Partner
CMS France
Alexandra Rohmert, Partner
Emmanuelle Brunel, Counsel
CMS Italy
Dietmar Zischg, Partner
CMS Morocco
Marc Veuillot, Partner
CMS Netherlands
Christian Delgado, Partner
Mark Ziekman, Partner
Christiaan Scholten van Aschat, Partner
CMS Spain
Luis Miguel de Dios, Partner
Bruchou, Fernández Madero & Lombardi, Argentina
Ignacio Minorini Lima
Pablo Falabella
Hergüner Bilgen Özeke, Istanbul, Turkiye
Süleyman Cengiz
Khaitan & Co., India
Rabindra Jhunjhunwala, Partner
Koutalidis Law Firm, Greece
Katia Protopapa, Partner
Santamarina y Steta S.C., Mexico
Jorge A. Barrero Stahl
Shearn Delamore & Co., Malaysia
Ng Swee Kee
Tozzini Freire Advogados, Brazil
Maria Beatriz Bueno Siqeira Nunes Kowalewski
Urenda Rencoret Orrego y Dörr, Chile
Sergio Orrego
Press Contact
presse@cms-hs.com
Social Media cookies collect information about you sharing information from our website via social media tools, or analytics to understand your browsing between social media tools or our Social Media campaigns and our own websites. We do this to optimise the mix of channels to provide you with our content. Details concerning the tools in use are in our privacy policy.